Scientific and Regulatory Policy Committee Points to Consider* for Determining and Reporting Cause of Death/Moribundity in Non-Rodent Species in Toxicity Studies
The Cause of Death in Non-Rodents (CODN) Working Group is an initiative under the Scientific and Regulatory Policy Committee (SRPC) of the Society of Toxicologic Pathology (STP), focused on understanding existing practices and expectations among pharmaceutical companies, academic entities, and contract research organizations (CROs) when it comes to identifying and reporting the "Cause of Death" (COD) or moribundity for early or unplanned necropsies in non-rodent animal species (mainly non-human primates [NHP] and dogs) within both GLP (Good Laboratory Practice) and non-GLP toxicity studies. A survey was sent out to STP members to collect data on industry practices for determining COD in animals that underwent unscheduled euthanasia or were found deceased. Other non-rodent animals (such as pigs and rabbits) were also included to evaluate different approaches taken with various species. The insights obtained led to the development of "Points to Consider" for establishing and documenting the COD in large animal toxicity studies. Four key considerations include utilizing information from both control and treated animals in the study, consideration of COD for cohabiting or co-shipped non-study animals, including additional evaluations to help rule-in or rule-out specific causes, and recording the COD consistently in pathology databases or reports as a standard practice.
Authors
- Eric Jacquinet (ORCID: https://orcid.org/0009-0000-9488-2080)
- Kathleen A. Funk (ORCID: https://orcid.org/0000-0002-4868-7900)
- Anna Maria Giusti (ORCID: https://orcid.org/0000-0002-5694-3732)
- John L. Vahle (ORCID: https://orcid.org/0000-0001-7964-9133)
- Laura Dill Morton
- Lindsay Tomlinson (ORCID: https://orcid.org/0009-0000-9527-7763)
- Elizabeth Neyens (ORCID: https://orcid.org/0000-0002-7702-0910)
- Annette Romeike (ORCID: https://orcid.org/0000-0002-1040-2869)
- Karyn Colman (ORCID: https://orcid.org/0000-0002-7054-8544)
- Curtis Colleton (ORCID: https://orcid.org/0000-0001-5582-8655)
- Lisa LaFranco-Scheuch (ORCID: https://orcid.org/0000-0003-1060-6383)
- Michael Boyle (ORCID: https://orcid.org/0000-0002-9740-1630)
- Shim‐mo Hayashi (ORCID: https://orcid.org/0000-0003-3242-9170)
- LuAnn McKinney
- Stephen O. Brennan
- Gary Cain
Institutions
- Roche (Switzerland) (CH)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Eli Lilly (United States) (US)
- Pfizer (United States) (US)
- Experimental Pathology Laboratories (US)
- Immunome (United States) (US)
- Novartis (United States) (US)
- National Institute of Health Sciences (JP)
- Vertex Pharmaceuticals (United States) (US)
- BioMarin (United States) (US)
- Tokyo University of Agriculture and Technology (JP)
Publication Details
- Journal
- Toxicologic Pathology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1177/01926233251321781
- Primary Topic
- Animal testing and alternatives
- Type
- article
- Field-Weighted Citation Impact
- 0.00